Quick Answer
UNITED THERAPEUTICS Corp reported Net Income Loss of $1.33 billion for the year ending 2025.
- UNITED THERAPEUTICS Corp showed an increase of +11.7% in Net Income Loss from 2024 to 2025.
- This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), UNITED THERAPEUTICS Corp's Net Income Loss has grown by 180.5%.
- Historical annual values: Fiscal year 2025: $1.33 billion | Fiscal year 2024: $1.20 billion | Fiscal year 2023: $984.80 million | Fiscal year 2022: $727.30 million | Fiscal year 2021: $475.80 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: